X-78136987-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000341864.6(TAF9B):āc.409C>Gā(p.Pro137Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000753 in 1,182,302 control chromosomes in the GnomAD database, including 1 homozygotes. There are 51 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000341864.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAF9B | NM_015975.5 | c.409C>G | p.Pro137Ala | missense_variant | 5/7 | ENST00000341864.6 | NP_057059.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAF9B | ENST00000341864.6 | c.409C>G | p.Pro137Ala | missense_variant | 5/7 | 1 | NM_015975.5 | ENSP00000339917 | P1 | |
TAF9B | ENST00000480681.1 | n.498C>G | non_coding_transcript_exon_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111598Hom.: 0 Cov.: 23 AF XY: 0.0000888 AC XY: 3AN XY: 33768
GnomAD3 exomes AF: 0.000127 AC: 23AN: 180566Hom.: 0 AF XY: 0.000245 AC XY: 16AN XY: 65244
GnomAD4 exome AF: 0.0000794 AC: 85AN: 1070704Hom.: 1 Cov.: 25 AF XY: 0.000142 AC XY: 48AN XY: 338796
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111598Hom.: 0 Cov.: 23 AF XY: 0.0000888 AC XY: 3AN XY: 33768
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.409C>G (p.P137A) alteration is located in exon 5 (coding exon 5) of the TAF9B gene. This alteration results from a C to G substitution at nucleotide position 409, causing the proline (P) at amino acid position 137 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at